DeepBiome Therapeutics Company
DeepBiome Therapeutics is an operator of a biotechnology company intended to develop a new drug discovery platform. The company's drug discovery platform leverages deep learning, microbiome, and synthetic biology technologies, enabling drug companies to release the therapeutic power of the microbiome. It was founded in 2017 and is based in Allston, Massachusetts.
Headquarters:
Allston, Massachusetts, United States
Funding Status:
Private
Employee Number:
7
Founded Date:
2017
Industry:
BioPharma AI
Technology:
AI-driven Drug Target Identification